Doe v. City of New York, 15 F.3d 264, 267 (2d Cir. 1994).
2.
Report of the Presidential Commission on the Human Immunodeficiency Virus Epidemic (Washington, D.C.: Presidential Commission on the Human Immunodeficiency Virus Epidemic, 1988).
3.
BayerR., Private Acts, Social Consequences: AIDS and the Politics of Public Health (New York: Free Press, 1989): At 101–03.
4.
Presidential Commission, supra note 2, at 73.
5.
American Bar Association, AIDS/HIV and Confidentiality, Model Policies and Procedures (Washington, D.C.: American Bar Association, 1991): At 2–3.
6.
GostinL.O., “Health Information Privacy,”Cornell Law Review, 8 (1995): At 491.
7.
See WestinA., Privacy and Freedom (New York: Atheneum, 1967).
8.
DoughtyR., Comment, “The Confidentiality of HIV-Related Information: Responding to the Resurgence of Aggressive Public Health Interventions in the AIDS Epidemic,”California Law Review, 82 (1994): At 127. 9. Id.
9.
BurrisS., “Testing, Disclosure, and the Right to Privacy,” in BurrisS., AIDS Law Today: A New Guide for the Public (New Haven: Yale University Press, 1993): At 121.
10.
Id. at 121–22.
11.
Mass. Gen. Laws Ann., ch. 111 § 70F (West 1995).
12.
Cal. Health & Safety Code § 199.21 (West Supp. 1995).
13.
Urbaniak v. Newton, 226 Cal. App. 3d 1128, 277 Cal. Rptr. 354 (Cal. Ct. App. 1991).
14.
AnnasG.J.GlantzL.H.RocheP.A., The Genetic Privacy Act and Commentary (Boston: Boston University School of Public Health, 1995): § 111.
15.
Wash. Rev. Code Ann. § 70.24.105 (West Supp. 1995).
16.
Id.
17.
GostinL.O., “Public Health Strategies for Confronting AIDS: Legislative and Regulatory Policy in the United States,”JAMA, 261 (1989): 1621–30.
18.
AnnasGlantzRoche, supra note 15, at 142–65.
19.
Bayer, supra note 3, at 102, 119.
20.
IsabellM.T., Health Care Reform: Lessons from the HIV Epidemic (New York: LAMBDA Legal Defense and Education Fund, 1993): At 80. The primary exception is California, which prohibits health insurers from requiring HIV tests. See Cal. Ins. Code § 199.09 (West 1993).
21.
29 U.S.C.A. § 1144(a) (1985).
22.
ParmetW.E., “Regulation and Federalism: Legal Impediments to State Health Care Reform,”American journal of Law & Medicine, XIX (1993): 121–44.
23.
42 U.S.C.A. § 12201(c) (1995); and Equal Employment Opportunity Commission, Interim Guidance on Application of ADA to Health Insurance, D.L.R. 109 d 22 (June 9, 1993).
24.
Isabell, supra note 21, at 69.
25.
For example, Ariz. Rev. Stat. Ann. § 36-664(A) (1993); and Wash. Rev. Code Ann. § 70.24.105.
26.
Cf. Tunkl v. Regents of Univ. of California, 60 Cal. 2d 92, 32 Cal Rptr. 33, 383 P.2d 441 (1963).
27.
Gostin, supra note 18.
28.
Gostin, supra note 6, at 514–15.
29.
For example, PiorkowskiJ.D.Jr., “Between a Rock and a Hard Place: AIDS and the Conflicting Physician's Duties of Preventing Disease Transmission and Safeguarding Confidentiality,”Georgetown Law Journal, 16 (1987): 169–202; and WeissC.D., “AIDS: Balancing the Physician's Duty to Warn and Confidentiality Concerns,”Emory Law Review, 38 (1989): 279–309.
30.
For example, Ga. Code Ann. § 24-9-47(g) (1995); and N.Y. Pub. Health Law § 2782.4 (West 1993).
31.
AnnasGlantzRoche, supra note 15, § 112(a)(7).
32.
But see Pa. Stat. Ann. § 7607(c) (West 1993) (requiring consent to include the date or event on which consent will expire).